Articles with public access mandates - Rachel Kerr (nee Midgley)Learn more
Not available anywhere: 6
Review
'Toxgnostics': an unmet need in cancer medicine
D Church, R Kerr, E Domingo, D Rosmarin, C Palles, K Maskell, ...
Nature Reviews Cancer 14 (6), 440-445, 2014
Mandates: Cancer Research UK, Wellcome Trust
Review
Biomarkers in early-stage colorectal cancer: Ready for prime time?
D Church, R Midgley, D Kerr
Digestive diseases 30 (Suppl. 2), 27-33, 2012
Mandates: Cancer Research UK
Review
Quinone Oxidoreductase-2–Mediated Prodrug Cancer Therapy
MR Middleton, R Knox, E Cattell, U Oppermann, R Midgley, R Ali, T Auton, ...
Science translational medicine 2 (40), 40ra50-40ra50, 2010
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Review
An open-label study of the safety and tolerability of pazopanib in combination with FOLFOX6 or CapeOx in patients with colorectal cancer
J Brady, P Corrie, I Chau, R Digumarti, LM Adams, J Botbyl, ...
Investigational new drugs 31, 1228-1235, 2013
Mandates: Cancer Research UK
Review
573P Multiparameter immunoprofiling reveals independent prognostic value of intraepithelial CD8 and intrastromal FoxP3 infiltrate in stage II/III colorectal cancer: Analysis of …
DN Church, A Frei, A McGuigan, R Sinha, A Harkin, TJ Iveson, ...
Annals of Oncology 34, S421-S422, 2023
Mandates: Cancer Research UK
Review
568P Single cell AI-based detection of DNA mismatch repair deficiency in 1,988 colorectal cancers reveals prognostic and predictive value in the SCOT trial
F Jabbar, M Nowak, AK Rodewald, L Gneo, T Tomasevic, A Harkin, ...
Annals of Oncology 34, S420, 2023
Mandates: Cancer Research UK, National Institute for Health Research, UK
Available somewhere: 74
Review
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
LYW Lee, JB Cazier, V Angelis, R Arnold, V Bisht, NA Campton, ...
The Lancet 395 (10241), 1919-1926, 2020
Mandates: Cancer Research UK, UK Medical Research Council, National Institute for …
Review
Genetic prognostic and predictive markers in colorectal cancer
A Walther, E Johnstone, C Swanton, R Midgley, I Tomlinson, D Kerr
Nature Reviews Cancer 9 (7), 489-499, 2009
Mandates: US National Institutes of Health
Review
Duration of adjuvant chemotherapy for stage III colon cancer
A Grothey, AF Sobrero, AF Shields, T Yoshino, J Paul, J Taieb, ...
New England Journal of Medicine 378 (13), 1177-1188, 2018
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Review
A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma
DH Palmer, RS Midgley, N Mirza, EE Torr, F Ahmed, JC Steele, ...
Hepatology 49 (1), 124-132, 2009
Mandates: Cancer Research UK
Review
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
LYW Lee, JB Cazier, T Starkey, SEW Briggs, R Arnold, V Bisht, S Booth, ...
The Lancet Oncology 21 (10), 1309-1316, 2020
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Review
Deep learning for prediction of colorectal cancer outcome: a discovery and validation study
OJ Skrede, S De Raedt, A Kleppe, TS Hveem, K Liestøl, J Maddison, ...
The Lancet 395 (10221), 350-360, 2020
Mandates: National Institute for Health Research, UK, Research Council of Norway
Review
Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26. 2, 12q13. 13 and 20q13. 33
RS Houlston, J Cheadle, SE Dobbins, A Tenesa, AM Jones, K Howarth, ...
Nature genetics 42 (11), 973-977, 2010
Mandates: Cancer Research UK, Chief Scientist Office, Scottish Executive
Review
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial
SJ Dutton, DR Ferry, JM Blazeby, H Abbas, A Dahle-Smith, W Mansoor, ...
The lancet oncology 15 (8), 894-904, 2014
Mandates: Cancer Research UK
Review
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study
E Domingo, L Freeman-Mills, E Rayner, M Glaire, S Briggs, L Vermeulen, ...
The lancet Gastroenterology & hepatology 1 (3), 207-216, 2016
Mandates: Academy of Medical Sciences, UK, Cancer Research UK, National Institute for …
Review
Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk
MG Dunlop, SE Dobbins, SM Farrington, AM Jones, C Palles, N Whiffin, ...
Nature genetics 44 (7), 770-776, 2012
Mandates: US National Institutes of Health, Swedish Research Council, Cancer Research …
Review
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis
D Rosmarin, C Palles, D Church, E Domingo, A Jones, E Johnstone, ...
Journal of Clinical Oncology 32 (10), 1031-1039, 2014
Mandates: US National Institutes of Health, Cancer Research UK, Wellcome Trust
Review
Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer
E Domingo, DN Church, O Sieber, R Ramamoorthy, Y Yanagisawa, ...
Journal of clinical oncology 31 (34), 4297-4305, 2013
Mandates: Cancer Research UK, Wellcome Trust
Review
Association analyses identify 31 new risk loci for colorectal cancer susceptibility
PJ Law, M Timofeeva, C Fernandez-Rozadilla, P Broderick, J Studd, ...
Nature communications 10 (1), 2154, 2019
Mandates: US National Institutes of Health, German Research Foundation, Helmholtz …
Review
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial
TJ Iveson, RS Kerr, MP Saunders, J Cassidy, NH Hollander, J Tabernero, ...
The Lancet Oncology 19 (4), 562-578, 2018
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Publication and funding information is determined automatically by a computer program